Omadacycline as a promising new agent for the treatment of infections with Mycobacterium abscessus

BACKGROUND: Despite intensive treatment regimens, the outcome of Mycobacterium abscessus infections is extremely poor and thus novel treatment regimens are needed. Although tigecycline seems to be one of the best options currently available, its long-term use is hampered by severe toxic side effects...

Descripción completa

Detalles Bibliográficos
Autores principales: Bax, Hannelore I, de Vogel, Corné P, Mouton, Johan W, de Steenwinkel, Jurriaan E M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7183808/
https://www.ncbi.nlm.nih.gov/pubmed/31236595
http://dx.doi.org/10.1093/jac/dkz267

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7183808/
https://www.ncbi.nlm.nih.gov/pubmed/31236595
http://dx.doi.org/10.1093/jac/dkz267

Ejemplares similares